Noribogaine and Neuroplasticity: What Happens in the Brain After Ibogaine

Noribogaine is the main active metabolite of ibogaine. The liver produces it within hours of treatment, and it remains in the body for days, acting on serotonin and opioid systems in ways that may explain why many patients report fewer cravings and a better mood in the weeks after ibogaine. Animal studies also show that ibogaine increases growth factors linked to neuroplasticity. Here is what is known, what is still being studied, and why this "window" matters for recovery.

Key takeaways

• The liver enzyme CYP2D6 converts ibogaine into noribogaine.
• Noribogaine has a much longer half-life than ibogaine and stays active for days.
• It inhibits serotonin reuptake and acts on kappa opioid receptors, effects associated with mood and reduced cravings.
• In animal studies, ibogaine raises GDNF and BDNF, proteins that support the growth and repair of neurons.
• The weeks after treatment are an opportunity to build new habits, which is why integration and aftercare are so important.

From ibogaine to noribogaine

After ibogaine is swallowed, it is absorbed and processed by the liver, mainly by the enzyme CYP2D6. This enzyme removes a small chemical group and produces noribogaine. Ibogaine itself is cleared relatively quickly, but noribogaine is eliminated slowly and can be detected in the blood for days.

Because CYP2D6 activity varies from person to person, and because some medications block it (such as fluoxetine, paroxetine and bupropion), the amount of ibogaine and noribogaine in the body can differ widely between patients. This is one reason careful dosing and cardiac monitoring are essential: noribogaine also affects the heart's QT interval.

What noribogaine does in the brain

Research, mostly in cells and animals, suggests noribogaine:

• Blocks serotonin reuptake, similar in principle to some antidepressants, which may contribute to improved mood.
• Acts on kappa opioid receptors in a biased way that may reduce the distress and cravings of withdrawal without causing euphoria.
• Acts on nicotinic receptors involved in reward and dependence.
• Is less hallucinogenic than ibogaine, which is why it has been studied as a potential medication in its own right.

Neuroplasticity: GDNF and BDNF

Neuroplasticity is the brain's ability to change, forming new connections and weakening old ones. Two proteins are central to this process:

• GDNF (glial cell line-derived neurotrophic factor) supports dopamine neurons, which are heavily affected by addiction. Rat studies found that ibogaine increases GDNF in the brain's reward area, and that this was linked to reduced alcohol seeking.
• BDNF (brain-derived neurotrophic factor) supports learning, memory and the formation of new synapses. Animal studies show ibogaine can increase BDNF in several brain regions.

These findings are exciting, but they come from animal research. They have not yet been directly measured in patients in controlled trials, so claims that ibogaine "repairs" or "regenerates" the brain go beyond current evidence.

Evidence from human studies

Human research has focused on outcomes rather than mechanisms. Observational studies in people with opioid use disorder report reduced withdrawal and cravings. The 2024 Stanford study in Nature Medicine found large improvements in functioning, PTSD, depression and anxiety in veterans with traumatic brain injury one month after treatment, along with improvements in concentration and processing speed. Follow-up brain-activity analyses from the same group, published in 2025, reported changes in cortical rhythms consistent with a more flexible brain state.

The "window of opportunity"

Patients often describe the weeks after ibogaine as a period of clarity: fewer cravings, less rumination, and more ability to see old patterns from the outside. Whether this is due to noribogaine, neuroplasticity, the psychological experience itself, or a combination, it is a window that closes if nothing changes in the person's life.

That is why the days after the session at our clinic are dedicated to rest, nutrition and daily integration sessions with a clinical psychologist, followed by a 90-day aftercare plan at home. Ibogaine can open the door; therapy, support and new routines are what keep it open.

Frequently asked questions

How long does noribogaine stay in the body?

Noribogaine is eliminated slowly and can remain in the blood for several days after a single dose of ibogaine. Its effects on mood and cravings may be felt for longer.

Is noribogaine available as a medicine?

Not yet. Noribogaine has been tested in early clinical studies, but it is not approved as a medication anywhere.

Does ibogaine really rewire the brain?

Animal research shows ibogaine increases growth factors such as GDNF and BDNF that support neuroplasticity, and human studies show meaningful improvements in symptoms. However, direct evidence of lasting brain rewiring in people is still limited.

Why is integration therapy important after ibogaine?

The weeks after treatment are when new habits are easiest to form. Integration therapy helps patients make sense of the experience and turn insights into concrete changes, which is key to long-term recovery.

References

• Koenig, X. and Hilber, K. "The anti-addiction drug ibogaine and the heart: a delicate relation." Molecules, 2015.
• Cherian, K. N. et al. "Magnesium–ibogaine therapy in veterans with traumatic brain injuries." Nature Medicine, 2024.
• Mash, D. C. et al. "Ibogaine detoxification transitions opioid and cocaine abusers between dependence and abstinence." Frontiers in Pharmacology, 2018.

Want to know if ibogaine is right for you? Our medical team reviews every case individually. Start your confidential screening.